The global human primary cell culture market size is accounted at USD 4.33 billion in 2025 and is forecasted to hit around USD 11.17 billion by 2034, representing a CAGR of 11.10% from 2025 to 2034. The North America market size was estimated at USD 1.60 billion in 2024 and is expanding at a CAGR of 11.23% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Human Primary Cell Culture Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Human Primary Cell Culture Market, by Product Type
8.1.1. Primary Cells
8.1.1.1. Market Revenue and Forecast
8.1.2. Reagents and Supplements
8.1.2.1. Market Revenue and Forecast
8.1.3. Instruments
8.1.3.1. Market Revenue and Forecast
8.1.4 Primary Cell Culture Media
8.1.4.1. Other Consumables
8.1.5 Primary Cell Culture Media
8.1.5.1. Market Revenue and Forecast
9.1. Human Primary Cell Culture Market, by Cell Type
9.1.1. Human Primary Cells
9.1.1.1. Market Revenue and Forecast
9.1.2. Animal Primary Cells
9.1.2.1. Market Revenue and Forecast
10.1. Human Primary Cell Culture Market, by Application
10.1.1. Cell & Gene Therapy Development
10.1.1.1. Market Revenue and Forecast
10.1.2. Drug Discovery and Development
10.1.2.1. Market Revenue and Forecast
10.1.3. Vaccine Production
10.1.3.1. Market Revenue and Forecast
10.1.4. Cancer Research
10.1.4.1. Market Revenue and Forecast
10.1.4. Prenatal Diagnosis
10.1.4.1. Market Revenue and Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Forecast
11.1. Human Primary Cell Culture Market, by End User
11.1.1. Contract Research Organizations (CROs)
11.1.1.1. Market Revenue and Forecast
11.1.2. Pharmaceutical and Biotechnology Companies
11.1.2.1. Market Revenue and Forecast
11.1.3. Contract Research Organizations (CROs)
11.1.3.1. Market Revenue and Forecast
11.1.4. Academic and Research Institutions
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product Type
12.1.2. Market Revenue and Forecast, by Cell Type
12.1.3. Market Revenue and Forecast, by Application
12.1.4. Market Revenue and Forecast, by End User
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product Type
12.1.5.2. Market Revenue and Forecast, by Cell Type
12.1.5.3. Market Revenue and Forecast, by Application
12.1.5.4. Market Revenue and Forecast, by End User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product Type
12.1.6.2. Market Revenue and Forecast, by Cell Type
12.1.6.3. Market Revenue and Forecast, by Application
12.1.6.4. Market Revenue and Forecast, by End User
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product Type
12.2.2. Market Revenue and Forecast, by Cell Type
12.2.3. Market Revenue and Forecast, by Application
12.2.4. Market Revenue and Forecast, by End User
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product Type
12.2.5.2. Market Revenue and Forecast, by Cell Type
12.2.5.3. Market Revenue and Forecast, by Application
12.2.5.4. Market Revenue and Forecast, by End User
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product Type
12.2.6.2. Market Revenue and Forecast, by Cell Type
12.2.6.3. Market Revenue and Forecast, by Application
12.2.6.4. Market Revenue and Forecast, by End User
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product Type
12.2.7.2. Market Revenue and Forecast, by Cell Type
12.2.7.3. Market Revenue and Forecast, by Application
12.2.7.4. Market Revenue and Forecast, by End User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product Type
12.2.8.2. Market Revenue and Forecast, by Cell Type
12.2.8.3. Market Revenue and Forecast, by Application
12.2.8.4. Market Revenue and Forecast, by End User
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product Type
12.3.2. Market Revenue and Forecast, by Cell Type
12.3.3. Market Revenue and Forecast, by Application
12.3.4. Market Revenue and Forecast, by End User
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product Type
12.3.5.2. Market Revenue and Forecast, by Cell Type
12.3.5.3. Market Revenue and Forecast, by Application
12.3.5.4. Market Revenue and Forecast, by End User
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product Type
12.3.6.2. Market Revenue and Forecast, by Cell Type
12.3.6.3. Market Revenue and Forecast, by Application
12.3.6.4. Market Revenue and Forecast, by End User
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product Type
12.3.7.2. Market Revenue and Forecast, by Cell Type
12.3.7.3. Market Revenue and Forecast, by Application
12.3.7.4. Market Revenue and Forecast, by End User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product Type
12.3.8.2. Market Revenue and Forecast, by Cell Type
12.3.8.3. Market Revenue and Forecast, by Application
12.3.8.4. Market Revenue and Forecast, by End User
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product Type
12.4.2. Market Revenue and Forecast, by Cell Type
12.4.3. Market Revenue and Forecast, by Application
12.4.4. Market Revenue and Forecast, by End User
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product Type
12.4.5.2. Market Revenue and Forecast, by Cell Type
12.4.5.3. Market Revenue and Forecast, by Application
12.4.5.4. Market Revenue and Forecast, by End User
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product Type
12.4.6.2. Market Revenue and Forecast, by Cell Type
12.4.6.3. Market Revenue and Forecast, by Application
12.4.6.4. Market Revenue and Forecast, by End User
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product Type
12.4.7.2. Market Revenue and Forecast, by Cell Type
12.4.7.3. Market Revenue and Forecast, by Application
12.4.7.4. Market Revenue and Forecast, by End User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product Type
12.4.8.2. Market Revenue and Forecast, by Cell Type
12.4.8.3. Market Revenue and Forecast, by Application
12.4.8.4. Market Revenue and Forecast, by End User
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product Type
12.5.2. Market Revenue and Forecast, by Cell Type
12.5.3. Market Revenue and Forecast, by Application
12.5.4. Market Revenue and Forecast, by End User
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product Type
12.5.5.2. Market Revenue and Forecast, by Cell Type
12.5.5.3. Market Revenue and Forecast, by Application
12.5.5.4. Market Revenue and Forecast, by End User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product Type
12.5.6.2. Market Revenue and Forecast, by Cell Type
12.5.6.3. Market Revenue and Forecast, by Application
12.5.6.4. Market Revenue and Forecast, by End User
13.1. ATCC (American Type Culture Collection)
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. BD (Becton, Dickinson and Company)
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Cell Biologics
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Corning Incorporated
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Danaher Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Fujifilm Irvine Scientific
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. GE Healthcare
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. InVivo Biosystems
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Lonza Group
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. PromoCell GmbH
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample